Dying cells actively regulate adaptive immune responses
- PMID: 28287107
- DOI: 10.1038/nri.2017.9
Dying cells actively regulate adaptive immune responses
Abstract
Dying cells have an important role in the initiation of CD8+ T cell-mediated immunity. The cross-presentation of antigens derived from dying cells enables dendritic cells to present exogenous tissue-restricted or tumour-restricted proteins on MHC class I molecules. Importantly, this pathway has been implicated in multiple autoimmune diseases and accounts for the priming of tumour antigen-specific T cells. Recent data have revealed that in addition to antigen, dying cells provide inflammatory and immunogenic signals that determine the efficiency of CD8+ T cell cross-priming. The complexity of these signals has been evidenced by the multiple molecular pathways that result in cell death and that have now been shown to differentially influence antigen transfer and immunity. In this Review, we provide a detailed summary of both the passive and active signals that are generated by dying cells during their initiation of CD8+ T cell-mediated immunity. We propose that molecules generated alongside cell death pathways - inducible damage-associated molecular patterns (iDAMPs) - are upstream immunological cues that actively regulate adaptive immunity.
Comment in
-
The pros and cons of dying tumour cells in adaptive immune responses.Nat Rev Immunol. 2017 Sep;17(9):591. doi: 10.1038/nri.2017.87. Epub 2017 Jul 31. Nat Rev Immunol. 2017. PMID: 28757605 No abstract available.
Similar articles
-
Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8+ T Cell Responses.J Virol. 2018 Oct 12;92(21):e00920-18. doi: 10.1128/JVI.00920-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30089700 Free PMC article.
-
Cross-presentation: underlying mechanisms and role in immune surveillance.Immunol Rev. 2005 Oct;207:166-83. doi: 10.1111/j.0105-2896.2005.00301.x. Immunol Rev. 2005. PMID: 16181335 Review.
-
Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.Cell Death Differ. 2009 Jul;16(7):991-1005. doi: 10.1038/cdd.2009.8. Epub 2009 Feb 20. Cell Death Differ. 2009. PMID: 19229247
-
The cross-priming pathway: a portrait of an intricate immune system.Scand J Immunol. 2007 Apr;65(4):311-9. doi: 10.1111/j.1365-3083.2007.01909.x. Scand J Immunol. 2007. PMID: 17386021 Review.
-
A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.Traffic. 2011 Dec;12(12):1677-85. doi: 10.1111/j.1600-0854.2011.01254.x. Epub 2011 Aug 16. Traffic. 2011. PMID: 21777358 Review.
Cited by
-
A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells in vivo by transgenic expression of a truncated GSDMD N-terminus.Front Immunol. 2022 Sep 15;13:991857. doi: 10.3389/fimmu.2022.991857. eCollection 2022. Front Immunol. 2022. PMID: 36189310 Free PMC article.
-
SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity.Front Immunol. 2024 Feb 13;15:1362224. doi: 10.3389/fimmu.2024.1362224. eCollection 2024. Front Immunol. 2024. PMID: 38415248 Free PMC article.
-
Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy.J Inflamm Res. 2024 Aug 14;17:5389-5413. doi: 10.2147/JIR.S470520. eCollection 2024. J Inflamm Res. 2024. PMID: 39161679 Free PMC article. Review.
-
The evolution of regulated cell death pathways in animals and their evasion by pathogens.Physiol Rev. 2022 Jan 1;102(1):411-454. doi: 10.1152/physrev.00002.2021. Physiol Rev. 2022. PMID: 34898294 Free PMC article. Review.
-
Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.J Immunol. 2022 Feb 1;208(3):539-547. doi: 10.4049/jimmunol.2100932. J Immunol. 2022. PMID: 35042789 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials